Affordable Access

Value of prostatic cancer screening in patients treated for benign prostatic hyperplasia with medical or minimally invasive modalities.

Authors
  • Orihuela, E
  • Kocurek, J N
  • Warren, M M
Type
Published Article
Journal
Archivos españoles de urología
Publication Date
Sep 01, 1997
Volume
50
Issue
7
Pages
821–824
Identifiers
PMID: 9350090
Source
Medline
License
Unknown

Abstract

Our findings suggest that systematic sextant PNbx for PSA > 4.0 ng/ml significantly reduces the risk of overlooking prostate cancer in patients undergoing treatment of BPH with modalities that do not provide tissue specimens.

Report this publication

Statistics

Seen <100 times